President Donald Trump’s “big, beautiful bill,” which he signed into law earlier this month, includes major wins for business ...

Still, some challenges need to be worked out for companies eying the unique manufacturing process. For SpaceX, its plans ...

SpaceX is planning a stock sale for employees and investors at a per-share price of $212, up from $185 in December, Bloomberg ...

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

Drug discovery is an important area with big business and social impact. From designing a new drug until it is finally approved, it takes tens of years and billions of dollars. We would like to apply ...

There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate ...

Therapeutic drug monitoring of program death-1 (PD-1) inhibitor Serplulimab in cancer patients is of clinical importance in predicting treatment efficacy and assessing adverse reactions. However, the ...

The 340B program should never be about padding hospital profits — it should be about helping people like me live long enough to need a retirement plan.

Pentagon to consider SpaceX alternative for Space Force satellite program The outcome of the review could impact the procurement of as many as 140 satellites for the Space Development Agency’s ...

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products EAGAN, Minn., June 25, 2025 /PRNewswire/ -- Only 8% of individuals (or 1 in 12) initiating a glucagon-like ...

Prime Therapeutics' leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years PR Newswire EAGAN, Minn., June 25, 2025 ...